Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy of Selective Laser Trabeculoplasty in Pseudophakic Patients

This study is enrolling participants by invitation only.
Sponsor:
Information provided by (Responsible Party):
University of Zurich
ClinicalTrials.gov Identifier:
NCT01467388
First received: November 3, 2011
Last updated: January 5, 2015
Last verified: December 2014

November 3, 2011
January 5, 2015
November 2011
December 2015   (final data collection date for primary outcome measure)
IOP [ Time Frame: t0 ] [ Designated as safety issue: No ]
Not Provided
Complete list of historical versions of study NCT01467388 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Efficacy of Selective Laser Trabeculoplasty in Pseudophakic Patients
Not Provided

Retrospective analysis of efficacy of selective laser trabeculoplasty in pseudophakic patients compared to phakic patients is performed.

Inclusion criterion are patients with glaucoma or ocular hypertension who underwent treatment with selective laser trabeculoplasty due to insufficient control of intraocular pressure during their routine treatment at the University Hospital Zurich / Division of Ophthalmology.

Not Provided
Observational
Observational Model: Case Control
Time Perspective: Retrospective
Not Provided
Not Provided
Non-Probability Sample
glaucoma patients
  • Glaucoma
  • Ocular Hypertension
Procedure: selective laser trabeculoplasty (SLT)
trabeculoplasty with an SLT-Laser to reduce intraocular pressure
Other Name: SLT-Laser, Tango Laser, Ellex Medical Pty. Ltd., 82 Gilbert Street, Adelaide, SA 5000 Australia
  • phacic
    Study patients who still have their own ocular lens
    Intervention: Procedure: selective laser trabeculoplasty (SLT)
  • pseudophacic
    Study patients who have an intraocular lens after cataract surgery
    Intervention: Procedure: selective laser trabeculoplasty (SLT)
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Enrolling by invitation
200
December 2015
December 2015   (final data collection date for primary outcome measure)

Inclusion criteria:

  • Patients with glaucoma or ocular hypertension who underwent selective laser trabeculoplasty.

Exclusion criteria:

  • Optic neuropathy other than glaucoma
Both
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Switzerland
 
NCT01467388
SLT-Pseudophakic-201
Not Provided
Not Provided
Not Provided
University of Zurich
University of Zurich
Not Provided
Study Director: 01 Studienregister MasterAdmins UniversitaetsSpital Zuerich
Principal Investigator: Jens Funk, Professor, MD University Hospital Zurich, Ophtalmic Clinic
University of Zurich
December 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP